News

Published on 7 Apr 2024 on Simply Wall St. via Yahoo Finance

Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're...


Article preview image

Evolent Health, Inc. (NYSE:EVH) shareholders might be concerned after seeing the share price drop 12% in the last month. But that scarcely detracts from the really solid long term returns generated by the company over five years. Indeed, the share price is up an impressive 134% in that time. To some, the recent pullback wouldn't be surprising after such a fast rise. The more important question is whether the stock is too cheap or too expensive today.

Since the long term performance has been good but there's been a recent pullback of 7.4%, let's check if the fundamentals match the share price.

See our latest analysis for Evolent Health

NYSE.EVH price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Evolent Health, Inc. (NYSE:EVH) Q1 2024 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH) Q1 2024 Earnings Call Transcript May 9, 2024 Evolent Health, Inc....

Insider Monkey via Yahoo Finance 10 May 2024

Earnings call: Evolent reports robust Q1 growth, raises 2024 revenue outlook By Investing.com

The company has raised its revenue guidance for 2024 by $115 million while maintaining its adjust...

Investing.com 10 May 2024

Evolent Health Inc (EVH) Surpasses Revenue Estimates Despite Net

Revenue: Reported $639.7 million, marking a 49.6% increase year-over-year, surpassing the estimat...

Guru Focus 10 May 2024

Why Diodes Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Friday's Mid-Day...

Shares of Diodes Incorporated DIOD fell sharply during Friday's session after the company reporte...

Benzinga 10 May 2024

Evolent Health Gains on Upbeat Guidance, Tops Q1 Estimates

Evolent Health, Inc. (NYSE: NYSE: EVH ) shares edged up 1.97% following the release of its...

Investing.com 8 May 2024

Recent 7.4% pullback isn't enough to hurt long-term Evolent Health (NYSE:EVH) shareholders, they're...

Evolent Health, Inc. (NYSE:EVH) shareholders might be concerned after seeing the share price drop...

Simply Wall St. via Yahoo Finance 7 Apr 2024

Here's What Analysts Are Forecasting For Evolent Health, Inc. (NYSE:EVH) After Its Annual Results

Shareholders of Evolent Health, Inc. (NYSE:EVH) will be pleased this week, given that the stock p...

Simply Wall St. via Yahoo Finance 26 Feb 2024

Evolent Health, Inc. (NYSE:EVH) Q4 2023 Earnings Call Transcript

Evolent Health, Inc. (NYSE:EVH) Q4 2023 Earnings Call Transcript February 22, 2024 Evolent Health...

Insider Monkey via Yahoo Finance 23 Feb 2024

Evolent Health Inc (EVH) Reports Robust Revenue Growth and Improved Adjusted EBITDA in 2023

Full Year Revenue: $1,963.9 million, marking a 45% increase from 2022.Net Loss: $(142.3) million ...

GuruFocus.com via Yahoo Finance 22 Feb 2024

Evolent Health shares leap on Q4 earnings beat and upbeat guidance

Evolent Health, Inc. (NYSE: NYSE: EVH ), a company dedicated to driving better health outcomes fo...

Investing.com 22 Feb 2024